Establishment and Characterization of a Continuous Human Chondrosarcoma Cell Line, ch-2879: Comparative Histologic and Genetic Studies with Its Tumor of Origin-Reference-Cited by-同舟云学术

Establishment and Characterization of a Continuous Human Chondrosarcoma Cell Line, ch-2879: Comparative Histologic and Genetic Studies with Its Tumor of Origin

Published:2003-06 Issue:6 Volume:83 Page:877-887
ISSN:0023-6837
Container-title:Laboratory Investigation
language:
Short-container-title:Lab Invest

Author:

Gil-Benso Rosario,Lopez-Gines Concha,López-Guerrero José Antonio,Carda Carmen,Callaghan Robert C,Navarro Samuel,Ferrer Jaime,Pellín Antonio,Llombart-Bosch Antonio

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference41 articles.

1. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton – biochemistry and cell biology of chondrosarcoma and its variants

2. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas

3. Changes inp14ARF do not play a primary role in human chondrosarcoma tissues

4. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma

5. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chorioallantoic Membrane Assay at the Cross-Roads of Adipose-Tissue-Derived Stem Cell Research;Cells;2023-02-12

2. Quantitative multiple fragment monitoring with enhanced in-source fragmentation/annotation mass spectrometry;Nature Protocols;2023-02-08

3. Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model;Clinical Orthopaedics & Related Research;2022-12-13

4. SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone;Cancers;2021-07-29

5. Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2;Cancer Control;2021-01